Critical Care
Conference Coverage
COVID-19: Peginterferon lambda may prevent clinical deterioration, shorten viral shedding
Activity against respiratory pathogens has been demonstrated for interferon lambda-1, a type III interferon.
Conference Coverage
Dexmedetomidine, propofol similar in ventilated adults with sepsis
Guidelines currently recommend either drug when light sedation is needed for adults on ventilators.
Conference Coverage
Telehealth helps cut mortality risk among ICU patients
In the traditional model, critical care specialists may be on-site during the day but on call after hours.
From the Journals
Ceftolozane-tazobactam found effective in critically ill patients with Pseudomonas aeruginosa infections
The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.
From the Journals
Baricitinib combo for COVID-19 accelerates recovery, study shows
The combination is intended for patients who need supplemental oxygen, mechanical ventilation, or extracorporeal membrane oxygenation.
From the Journals
One-third of critical illness survivors emerge from ICU with functional deterioration
One-third of patients who survived nonsurgical ICU admission had evidence of functional status decline.
From the Journals
COVID-19: Thromboembolic events high despite prophylaxis
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight...
Conference Coverage
Unneeded meds at discharge could cause harm
The problem stems from a technology disconnect when patients are transferred from the ICU to the general population.
Conference Coverage
Score predicts risk for ventilation in COVID-19 patients
“If mild COVID disease in young patients caused cardiac injury, you can imagine what it can do to older patients with severe disease,” Dr....
Conference Coverage
Certain statins linked to lower mortality risk in patients admitted for sepsis
Statin use was associated with lower mortality, compared with no use, with hydrophilic and synthetic statins besting lipophilic and fungal-derived...
From the Journals
Bronchoscopy can be conducted safely patients with severe COVID-19
“The most surprising data was the 65% rate of secondary infection with bronchoalveolar lavage.”